S.C Pelican Impex S.R.L

Oradea 410469

1 studies enrolling now · 6 studies all time

What they study most

Dyslipidemia, First Line Non-Small Cell Lung Cancer, Moderately to Severely Active Crohn Disease, Type2 Diabetes, Ulcerative Colitis

Studies at this site

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease — Recruiting now
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
• Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis — Completed